14-day Premium Trial Subscription Try For FreeTry Free
Reata Pharmaceuticals, Inc. (RETA) delivered earnings and revenue surprises of 8.09% and 62.24%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for th

Intercept Pharmaceuticals (ICPT) Reports Q3 Loss, Tops Revenue Estimates

12:15pm, Tuesday, 01'st Nov 2022 Zacks Investment Research
Intercept (ICPT) delivered earnings and revenue surprises of -159.49% and 2.62%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
PLANO, Texas--(BUSINESS WIRE)--Reata Pharmaceuticals, Inc. (Nasdaq: RETA) (“Reata,” the “Company,” “our,” “us,” or “we”), a clinical-stage biopharmaceutical company, today announce

2 On-Fire Biotech Stocks That Are Crushing the Bear Market

01:30pm, Monday, 31'st Oct 2022 The Motley Fool
The biotech sector is down this year, but these two biopharmaceutical stocks have delivered strong returns.
The biotech sector is down this year, but these two biopharmaceutical stocks have delivered strong returns.
Upgrades According to Raymond James, the prior rating for Fortis Inc (NYSE:FTS) was changed from Market Perform to Outperform. In the second quarter, Fortis showed an EPS of $0.45, compared to $0.45 f
Gainers Acorda Therapeutics, Inc. (NASDAQ: ACOR) surged 163.8% to close at $0.8970 on Monday after the company announced a $16.5 million award and royalty/supply relief in the AMPYRA arbitration case

Reata (RETA) Up After FDA Scraps AdCom Meeting for NDA Filing

04:52pm, Monday, 17'th Oct 2022 Zacks Investment Research
The FDA decides not to hold an advisory committee meeting for Reata Pharmaceuticals' (RETA) regulatory filing seeking approval for omaveloxolone in Friedreich's Ataxia.
The FDA decides not to hold an advisory committee meeting for Reata Pharmaceuticals' (RETA) regulatory filing seeking approval for omaveloxolone in Friedreich's Ataxia.

Reata Pharmaceuticals, Inc. (RETA) Stock Jumps 20.6%: Will It Continue to Soar?

12:05pm, Monday, 17'th Oct 2022 Zacks Investment Research
Reata Pharmaceuticals, Inc. (RETA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further s
Reata Pharmaceuticals, Inc. (RETA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further s
Gainers Agrify Corporation (NASDAQ: AGFY) climbed 53.8% to close at $1.45. FedNat Holding Company (NASDAQ: FNHC) gained 48% to settle at $0.52. IMARA Inc. (NASDAQ: IMRA) shares climbed 46.9% to close

Dow Dips 375 Points; S&P 500 Down Over 2%

06:33pm, Friday, 14'th Oct 2022 Benzinga
U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping around 375 points on Friday. The Dow traded down 1.25% to 29,662.76 while the NASDAQ fell 2.68% to 10,363.83. The S&P 50
Gainers Intelligent Living Application Group Inc. (NASDAQ: ILAG) surged 77.7% to $9.35. Gravitas Education Holdings, Inc. (NASDAQ: GEHI) shares jumped 66% to $24.90. Avenue Therapeutics, Inc. (NASDAQ

Nasdaq Tumbles Over 200 Points; Crude Oil Falls Sharply

04:05pm, Friday, 14'th Oct 2022 Benzinga
U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping more than 200 points on Friday. The Dow traded down 0.74% to 29,817.07 while the NASDAQ fell 2.09% to 10,426.14. The
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE